![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: C9orf16 |
Gene summary for C9ORF16 |
![]() |
Gene information | Species | Human | Gene symbol | C9orf16 | Gene ID | 79095 |
Gene name | bublin coiled coil protein | |
Gene Alias | C9orf16 | |
Cytomap | 9q34.11 | |
Gene Type | protein-coding | GO ID | GO:0008150 | UniProtAcc | Q9BUW7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79095 | C9orf16 | AEH-subject1 | Human | Endometrium | AEH | 8.64e-03 | 8.15e-02 | -0.3059 |
79095 | C9orf16 | AEH-subject2 | Human | Endometrium | AEH | 4.85e-09 | 1.98e-02 | -0.2525 |
79095 | C9orf16 | AEH-subject3 | Human | Endometrium | AEH | 1.17e-06 | -1.06e-01 | -0.2576 |
79095 | C9orf16 | AEH-subject4 | Human | Endometrium | AEH | 2.37e-06 | -2.75e-01 | -0.2657 |
79095 | C9orf16 | AEH-subject5 | Human | Endometrium | AEH | 2.21e-11 | -4.08e-01 | -0.2953 |
79095 | C9orf16 | EEC-subject1 | Human | Endometrium | EEC | 2.14e-11 | -3.36e-01 | -0.2682 |
79095 | C9orf16 | EEC-subject2 | Human | Endometrium | EEC | 8.74e-14 | 2.13e-01 | -0.2607 |
79095 | C9orf16 | EEC-subject3 | Human | Endometrium | EEC | 7.35e-49 | -4.58e-01 | -0.2525 |
79095 | C9orf16 | EEC-subject4 | Human | Endometrium | EEC | 2.16e-08 | -2.78e-01 | -0.2571 |
79095 | C9orf16 | EEC-subject5 | Human | Endometrium | EEC | 9.65e-10 | -1.50e-01 | -0.249 |
79095 | C9orf16 | GSM5276934 | Human | Endometrium | EEC | 4.56e-18 | -4.69e-01 | -0.0913 |
79095 | C9orf16 | GSM5276937 | Human | Endometrium | EEC | 3.18e-04 | -3.22e-01 | -0.0897 |
79095 | C9orf16 | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 3.34e-33 | -4.07e-01 | -0.1869 |
79095 | C9orf16 | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 3.63e-29 | -5.43e-01 | -0.1875 |
79095 | C9orf16 | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 7.10e-34 | -6.08e-01 | -0.1883 |
79095 | C9orf16 | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 7.04e-40 | -5.88e-01 | -0.1934 |
79095 | C9orf16 | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 3.56e-47 | -4.06e-01 | -0.1917 |
79095 | C9orf16 | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 1.01e-52 | -4.52e-01 | -0.1916 |
79095 | C9orf16 | GSM6177623_NYU_UCEC3_Vis | Human | Endometrium | EEC | 5.39e-07 | 4.05e-02 | -0.1269 |
79095 | C9orf16 | LZE2T | Human | Esophagus | ESCC | 2.39e-03 | 9.65e-01 | 0.082 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
C9orf16 | SNV | Missense_Mutation | c.210N>A | p.Phe70Leu | p.F70L | Q9BUW7 | protein_coding | tolerated(0.15) | possibly_damaging(0.77) | TCGA-AD-6895-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
C9orf16 | SNV | Missense_Mutation | novel | c.163C>A | p.Arg55Ser | p.R55S | Q9BUW7 | protein_coding | tolerated(0.07) | benign(0.297) | TCGA-55-6972-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |